Anvimo 240
Brand Name: Anvimo 240
Composition: Letermovir Tablets 240 mg
Product Description
Medical Info
Anvimo 240, manufactured by Zydus, contains the active ingredient Letermovir at a strength of 240 mg per tablet. Letermovir is an antiviral medication specifically indicated for the prophylaxis (prevention) of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant (HSCT). It works by inhibiting the CMV DNA terminase complex, which is essential for viral replication. Anvimo 240 is available by prescription only (Rx) and is usually started after the transplant. The tablets should be stored according to the package directions, typically below 25°C, and kept away from children. Always consult a healthcare professional for specific usage instructions.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
